Lataa...
Cell therapy with intravascular administration of mesenchymal stromal cells continues to appear safe: An updated systematic review and meta-analysis
BACKGROUND: Characterization of the mesenchymal stromal cell (MSC) safety profile is important as this novel therapy continues to be evaluated in clinical trials for various inflammatory conditions. Due to an increase in published randomized controlled trials (RCTs) from 2012–2019, we performed an u...
Tallennettuna:
| Julkaisussa: | EClinicalMedicine |
|---|---|
| Päätekijät: | , , , , , , , , , , , , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6970160/ https://ncbi.nlm.nih.gov/pubmed/31989101 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.eclinm.2019.100249 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|